PF-06671008 Dose Escalation Study in Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
The study will evaluate the safety, pharmacokinetics and pharmacodynamics of increasing doses of PF-06671008 in patients with advanced solid tumors with the potential to have P-cadherin expression. The study will then expand to look at the selected dose in patients with P-cadherin expressing TNBC, CRC or NSCLC.
创建时间：
2016-04-15
